Albion Financial Group Crispr Therapeutics Ag Transaction History

Albion Financial Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$39.19 - $65.67 $9,248 - $15,498	-236 Reduced 94.02%	15 $0
Q1 2022 May 09, 2022	SELL	$53.19 - $79.24 $957 - $1,426	-18 Reduced 6.69%	251 $16,000
Q3 2021 Oct 19, 2021	BUY	$110.2 - $156.64 $16,970 - $24,122	154 Added 133.91%	269 $30,000
Q2 2021 Aug 12, 2021	BUY	$100.84 - $161.89 $11,596 - $18,617	115 New	115 $19,000

494

64.3M

1.68M

1.95M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.88B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

Stay updated on Albion Financial Group with notifications on news.